Gemcitabine Completed Phase 1 Trials for Unspecified Childhood Solid Tumor, Protocol Specific Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00005577Gemcitabine in Treating Children With Refractory Solid Tumors